[HIV-STD-Prevention] Register Today! Meth as a Driver of the HIV Epidemic

[Pearson Shelley M]

View this email online<https://urldefense.com/v3/__https:/app.getresponse.com/view.html?x=a62b&m=BS79pe&mc=Iq&s=BSxVxKj&u=a08&z=EVpNMNG&__;!!F9wkZZsI-LA!QeB6B8enQw-CaPMAhDAwXSnJ-cIBTDEHFIwpzN9woNrclRPQb-Te5vRHyBr6ojPalyzoZA$> if it doesn't display correctly


[https://m.gr-cdn-8.com/getresponse-a08/photos/dfcc0ea5-426f-45b4-8b99-3a649ba43a67.png?img1632323496613]
Register for the Event ><https://urldefense.com/v3/__https:/app.getresponse.com/click.html?x=a62b&lc=SF3Ilg&mc=Iq&s=BSxVxKj&u=a08&z=EFvRIlC&__;!!F9wkZZsI-LA!QeB6B8enQw-CaPMAhDAwXSnJ-cIBTDEHFIwpzN9woNrclRPQb-Te5vRHyBr6ojPiV2lWGA$>
Meth as a Driver of the HIV Epidemic
Webinar
Thursday, September 30th, 2021
 9 - 10 AM PST | 10 - 11 AM MST | 11 - 12 PM CST | 12 - 1 PM EST
Methamphetamine is a key driver of the HIV epidemic in jurisdictions nationwide. HIV prevention and treatment, both key efforts in the EHE strategy are negatively affected by the meth crisis.

Presenters will review the epidemiology of the Methamphetamine epidemic as it relates to HIV, including biological changes that affect brain function, the psychodynamics of meth use and the implications for EHE efforts.

The webinar seeks to dispel the myth that very little can be done to engage and treat meth users to achieve positive outcomes. The presenters will share examples of evidence-based and evidence-informed interventions that can assist users to achieve better HIV and health outcomes, with a focus on contingency management (CM).

Participants are encouraged to view TAP-in’s previous webinar:
Addressing Substance Use Disorders as a Strategy to End the HIV Epidemic
That webinar can be found at: https://targethiv.org/library/tap-in-addressing-substance-use-disorders-suds-strategy-end-hiv-epidemic<https://urldefense.com/v3/__https:/app.getresponse.com/click.html?x=a62b&lc=SF3IOL&mc=Iq&s=BSxVxKj&u=a08&z=Etm0SOQ&__;!!F9wkZZsI-LA!QeB6B8enQw-CaPMAhDAwXSnJ-cIBTDEHFIwpzN9woNrclRPQb-Te5vRHyBr6ojOv7MBuEg$>

GET TO KNOW YOUR PANEL

[https://m.gr-cdn-8.com/getresponse-a08/photos/8d6c2352-3d53-4a06-a269-570e8ffbf9b8.jpg?img1632323496613]
Beth A. Rutkowski, M.P.H.

Beth Rutkowski received her Master of Public Health degree, with an emphasis on epidemiology and quantitative methods, from the University of Medicine and Dentistry of New Jersey, School of Public Health. She has been associated with UCLA’s Integrated Substance Abuse Programs (ISAP) since December 2000, and currently serves as the Director of Training and Co-Director of the SAMHSA-supported Pacific Southwest Addiction Technology Training Center. The majority of Ms. Rutkowski’s time is focused on the development of synchronous and asynchronous training and intensive technical assistance packages based on evidence-based substance use disorder research and targeted to the community at large. In addition, she organizes and conducts conferences and trainings throughout the Pacific Southwest region (HHS Region 9, covering AZ, CA, HI, NV, and the six U.S. Affiliated Pacific Jurisdictions) on scientifically validated interventions and topics. Ms. Rutkowski is a NIATx-certified process improvement coach, and has directed several statewide, regional, and local process improvement change project initiatives, coaching hundreds of substance use disorder, HIV, and mental health intra- and interagency change teams. Ms. Rutkowski has authored and edited numerous peer reviewed research articles, book chapters, special issues, technical reports, training curricula, and conference presentations on numerous topics, including: treatment evaluation, research-practice partnerships, process improvement strategies for improving access to and engagement and retention in substance use disorder, behavior health, HIV care, and criminal justice (e.g., community probation) settings, prescription drug misuse, the impact of stimulants (methamphetamine and cocaine) on brain, body, and behavior, synthetic drugs, SBIRT, HIV and substance use, medications for opioid and alcohol use disorder, best practices in substance use disorder treatment, and strategies to use epidemiological data to make informed programmatic funding decisions.

[https://m.gr-cdn-8.com/getresponse-a08/photos/68ce2a48-0940-405a-afdc-bdc057a9c558.jpg?img1632323496613]
Dr. Jessica L. Montoya, PhD

Dr. Jessica L. Montoya, PhD, is an Assistant Professor in the Department of Psychiatry at UC San Diego, a clinical psychologist at the UC San Diego Owen Clinic – an HIV care clinic, and a consultant of the UC San Diego Dissemination and Implementation Science Center. She has a K23 mentored patient-oriented research career development award funded by NIDA, titled, "An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine." Broadly, her implementation science research focuses on identifying and evaluating strategies for implementing evidence-based practices for substance use disorders in HIV care clinics.

[https://m.gr-cdn-8.com/getresponse-a08/photos/8bb95eab-b1ac-4766-b0e0-2e255cb3456a.jpg?img1632323496613]
Max Sepulveda, MPA

Max Sepulveda, MPA, is the Managing Director for Harm Reduction Services at Housing Works (HW). Mr. Sepulveda has been working with high-risk populations since the 1090’s providing care coordination, health education and care navigation services. Since his tenure at Housing Works in 2009, he has been involved in the provision of care coordination and harm reduction to marginalized populations. In 2012 Mr. Sepulveda started to oversee several harm-reduction programs in the organization. These programs provide syringe exchange, harm reduction education, HIV/HCV/STD prevention interventions, Hepatitis C care navigation, and care coordination services. In addition to managing HW’s ReCharge Program providing Methamphetamine harm reduction services to MSM and transgender individuals in NYC.

Register for the Event ><https://urldefense.com/v3/__https:/app.getresponse.com/click.html?x=a62b&lc=SF3Ilg&mc=Iq&s=BSxVxKj&u=a08&z=E9Tv9UO&__;!!F9wkZZsI-LA!QeB6B8enQw-CaPMAhDAwXSnJ-cIBTDEHFIwpzN9woNrclRPQb-Te5vRHyBr6ojMovh9qvw$>

To learn more about TAP-in or to access any other TAP-in webinar recordings, please visit https://targethiv.org/ta-org/tap-in<https://urldefense.com/v3/__https:/app.getresponse.com/click.html?x=a62b&lc=SF3Iiy&mc=Iq&s=BSxVxKj&u=a08&z=EQXo9Is&__;!!F9wkZZsI-LA!QeB6B8enQw-CaPMAhDAwXSnJ-cIBTDEHFIwpzN9woNrclRPQb-Te5vRHyBr6ojPQVdIbQQ$>

[https://m.gr-cdn-8.com/getresponse-a08/photos/0c4526d1-11c1-4474-b9df-11559715b5ad.png?img1632323496613]
CAI, 505 Eighth Avenue 1900, New York, NY 10018, United States
You may unsubscribe<https://urldefense.com/v3/__https:/app.getresponse.com/unsubscribe.html?x=a62b&m=BS79pe&mc=Iq&s=BSxVxKj&u=a08&z=Ezx9hnR&pt=unsubscribe__;!!F9wkZZsI-LA!QeB6B8enQw-CaPMAhDAwXSnJ-cIBTDEHFIwpzN9woNrclRPQb-Te5vRHyBr6ojM1sXn9HQ$> or change your contact details<https://urldefense.com/v3/__https:/app.getresponse.com/change_details.html?x=a62b&m=BS79pe&s=BSxVxKj&u=a08&z=EC7MVFV&pt=change_details__;!!F9wkZZsI-LA!QeB6B8enQw-CaPMAhDAwXSnJ-cIBTDEHFIwpzN9woNrclRPQb-Te5vRHyBr6ojNgoYxsRw$> at any time.


________________________________

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://omls.oregon.gov/pipermail/hiv-std-prevention/attachments/20210927/7accdcf7/attachment-0001.html>